Professional Documents
Culture Documents
Microchemical Journal
journ al h om e pa ge : ww w . e l s e v i e r . c o m / l o c a t e / m i c r oc
a r t i c l e i n f o
a b s t r a c t
Article history:
Received 17 March 2017 In this study, an HPLC-DAD method was developed and validated for the quantification of bioactive phenolics
Received in revised form 8 June 2017 in herbal medicines containing Cynara scolymus (Globe artichoke), Maytenus ilicifolia Mart ex Reiss
Accepted 21 July 2017 “Espinheira santa” and Ptychopetalum uncinatum “Marapuama”. The samples were lyophilized and 5.0 g of solid
Available online 21 July 2017 were extract- ed with 30 mL of methanol acidified with 100 μL of concentrated HCl, under magnetic stirring at 40
°C for 30 min. Separation was carried out on a C18 column with analytical solvents constituting a binary
Keywords: elution mixture, consisting of (A) ultrapure water (Millipore, USA), containing 1.0% acetic acid (v v−1) and
Bioactive phenolics (B) methanol (HPLC grade). Spectrophotometric detection was performed at a wavelength of 260 nm for
Herbal medicines vanillic acid; 280 nm for (+) – catechin and 330 nm for chlorogenic acid. The method to determine bioactive
Quality control
phenolics in herbal medicines showed adequate linearity, repeatability and accuracy. The limits of detection
HPLC-DAD
(LOD) and quantification (LOQ) were 0.025 μg g−1 and 0.031 μg g−1, respectively. The concentrations
(minimum–maximum in mg g−1) of chlorogenic acid (in samples containing C. scolymus) and vanillic acid (in
herbal medicines containing P. uncinatum “Marapuama”) ranged from 71.28 to 925.99 and 17.35 to 19.21,
respectively. The catechin content was
0.69 mg g−1 in Maytenus ilicifolia Mart ex Reiss “Espinheira santa”. Therefore, the results showed that the
devel- oped method is simple, less toxic, fast and reliable for the determination of bioactive phenolics in herbal
medicines.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
medicinal plants has been widely studied [4] due to their
pharmacolog- ical and antinutritional activities, besides the inhibition
The World Health Organization (WHO), in 1991, recognized the
of lipid oxida- tion and fungal proliferation, as well as their
im- portance of natural products and advocated the formulation of
participation in processes responsible for colour, astringency and
policies and regulations for the use of traditional medicines [1]. In this
smell in various foods [5]. Poly- phenols are secondary metabolites
context, the consumption of Medicinal Plants and Herbal Medicines
widely distributed in the plant king- dom and act as: antioxidants,
has been in- creasing, and the need for greater quality control by the
metal chelators, antimutagens, anticancer, antifungals and anti-
Pharmaceutical Industry becomes a relevant factor to ensure safety
allergic substances [6].
and efficacy [2,3].
Cynara scolymus L. (Asteraceae) “Globe artichoke”, Maytenus ilicifolia
The search for natural antioxidants has increased with the
Mart ex Reiss (Celastraceae) and Ptychopetalum uncinatum
discovery of the properties of components that are produced by
(Olacaceae) are popularly known in Brazil as “alcachofra”, “espinheira
plants through their secondary metabolism. The presence of
santa” and “marapuama”, respectively, and are grown in South
phenolic compounds in
America. “Globe ar- tichoke” is used in the treatment of: biliary and
hepatic diseases, eczema and rashes, constipation, diabetes mellitus
☆ Selected paper from the 4th Uruguayan Conference on Analytical Chemistry, 25-28 and dyslipidemia, as an antisclerotic agent [7,8]. Furthermore, it is
September, 2016, at the Convention Center-Torre de las Telecomunicaciones ANTEL, in popularly used as a coadjuvant in the treatment of anemia, scurvy and
Montevideo. rickets due to its iron, vitamin C and calcium content [9]. In the
* Corresponding author.
literature, studies have shown that leaves contain phenolic chemical
E-mail address: afjunior@uneb.br (A. de Freitas Santos Jú nior).
constituents, including
http://dx.doi.org/10.1016/j.microc.2017.07.009
0026-265X/© 2017 Elsevier B.V. All rights
reserved.
R.R. Sá et al. / Microchemical Journal 135 (2017)
caffeine-like acids (chlorogenic acid, 1,5-dicapheoilquinic acid and drugstores in Salvador, Bahia, Brazil. The formulations did not contain
cinnarine), flavonoids (scolymoside and cynaroside), sesquiterpenes excipients, according to
(Cynaropricrin) in a smaller amount, and various aliphatic acids,
espe- cially hydroxyacids (lactic, glycolic, malic and
hydroxymethylacrylic acids) [10,11,12].
Studies with Maytenus ilicifolia Martius ex Reiss began in the
1960′s,
stimulated by its effectiveness in the treatment of ulcers and cancer,
in addition to its antioxidant effect [13,14,15,16]. In the literature,
phyto- chemical studies using High performance liquid
chromatography (HPLC) showed that leaves containing phenolic
compounds, quercetin and kaempferol; condensed tannins (e.g.
catechin, epicatechin, and epi- gallocatechin) as monomers and
triterpenes, such as friedelin, reduce gastric hypersecretion [17],
motility and gastric emptying [18], in addi- tion to presenting a
hypotensive effect [19].
Ptychopetalum uncinatum is native to the Amazon rainforest,
region- ally known as “marapuama, muiratã , muirapuama, pau-
homem and liriosma"” There are hypotheses about its secondary plant
metabolism, and data on its phytochemical composition and
pharmacological func- tions are not yet fully elucidated. However, few
studies report its use for sexual dysfunction and stimulating action on
the central nervous system, attributed to the presence of alkaloids,
tannins and essential oils [20,21,22].
Currently, monitoring the quality of pharmaceutical solid oral dos-
age forms (capsules and tablets) has gained greater importance to
phar- maceutical companies and regulatory authorities. Several
herbal products are in oral solid form and, despite the use of this test
in the quality control of synthetic drugs, their use in the evaluation of
natural products has not yet been widely adopted [23,24,25].
Although the use of Globe artichoke and “Espinheira santa” is
wide-
spread in medicine and public health in Brazil and other countries of
South America, as well as the high consumption of Ptychopetalum
uncinatum in regions of Brazil, in vitro monitoring of bioactive phenolics
by HPLC-DAD was proposed. In this study, quantification methods by
HPLC were developed and validated in order to evaluate gelatin
capsules of Maytenus ilicifolia Mart ex Reiss and Ptychopetalum
uncinatum, besides plant drugs and tablets containing Cynara scolymus
L. “Globe artichoke” purchased from the market, using the release of
two phenolic acids (Chlorogenic and vanillic acids) and catechin,
quantified by HPLC-DAD.
2. Experimental
were transferred to volumetric flasks to obtain the final phenolic in Ptychopetalum uncinatum were slighty higher in the
concentrations of 1.0; 5.0; 15.0; 20.0; 25.0; 30.0; 40.0 and 50.0 μg capsules. The
mL−1. Each solution was prepared in triplicate. Linearity was evaluated
by linear regression, which was calculated by the least square
regression method. A good lin- earity was obtained for all observed
lines (r = 0.9995–0.9999).
Fig. 1. Overlay of spiked sample (rose) and standard stock solution (green/blue/black) chromatograms. (Tr = retention time) for chlorogenic acid; vanillic acid and catechin.
Table 1
Concentration of bioactive phenolics (mg g−1) and in Cynara scolymus L. “Globe artichoke”, Ptychopetalum uncinatum “Marapuama” and Maytenus ilicifolia Mart ex Reiss “Espinheira-
Santa”.
Sample AC AV CT
CT = catechin, AC = chlorogenic acid and AV = vanillic acids/* = recovery, % (means ± SD)/** = average of three herbal medicines (gelatin capsules) analyzed (means ± SD).
R.R. Sá et al. / Microchemical Journal 135 (2017)
Fig. 2. Representative HPLC-DAD chromatographic profile of commercial extracts showing peaks corresponding to the isolated standards: (A) chlorogenic acid in samples containing C.
scolymus “Globe artichoke” – Black: plant drug and Pink: herbal medicine (tablets); (B) catechin in samples containing Maytenus ilicifolia Mart ex Reiss “Espinheira-Santa”– Blue:
Herbal medicine 1; Black: Herbal medicine 2 and Pink: Herbal medicine 3; (C) vanillic acid in samples containing P. uncinatum “Marapuama”– Black: plant drug and Pink: herbal
medicine (gelatin capsules).
commercial and local varieties adapted to different environments, can polysaccharide from the medicinal plant Maytenus ilicifolia, Carbohydr. Polym. 78
differ in chemical composition, especially of the polyphenolic fraction, (2009) 361–363.
and hence exhibit different nutraceutical and pharmacological [14] P.M. Costa, P.M.P. Ferreira, V.S. Bolzani, M. Furlan, V.A.F.M. Santos, J. Corsino, M.O.
Moraes, L.V. Costa-Lotufo, R.C. Montenegro, C. Pessoa, Antiproliferative activity of
properties. pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells,
Toxicol. In Vitro 22 (2008) 854–863.
[15] J.C.R. Vellosa, N.M. Khalil, V.A.F. Formenton, V.F. Ximenes, L.M. Fonseca, M. Furlan,
4. Conclusions
I.L. Brunetti, O.M.M.F. Oliveira, Antioxidant activity of Maytenus ilicifolia root bark,
Fitoterapia 77 (2006) 243–244.
In recent decades, the consumption of Medicinal Plants and Herbal [16] R.S. Oliveira, S.C. Cunha, W. Colaço, Review of Maytenus ilicifolia Mart. Ex
Reissek, Celastraceae Contribution to the study of pharmacological properties,
Medicines has been increasing, and the need for greater control of
Rev. Bras. Farm. 19 (2009) 650–659.
their quality by the Pharmaceutical Industry, becomes relevant to en- [17] C.H. Baggio, C.S. Freitas, G.M. Otofuji, T.R. Cipriani, L.M. Souza, G.L. Sassaki, M.
sure safety and efficacy. Iacomini, M.C.A.M. Marques, S. Mesia-Vela, Flavonoid-rich fraction of Maytenus
The proposed method meets the requirements of green and ilicifolia Mart. Ex. Reiss protects the gastric mucosa of rodents through
inhibition of both H+, K+ - ATPase activity and formation of nitric oxide, J.
sustain- able chemistry, using less toxic solvents at a lower cost. The Ethnopharmacol. 113 (2007) 433–440.
analytical performance showed that the method was satisfactory, [18] C.H. Baggio, C.S. Freitas, B. Mayer, A.C. Santos, A. Twardowschy, F.B. Potrich, T.R.
considering the figures of merit and the parameters that evaluate Cipriani, L.M. Souza, G.L. Sassaki, M. Iacomini, M.C. Marques, S. Mesia-Vela,
Musca- rinic-dependent inhibition of gastric emptying and intestinal motility by
separation efficiency. Phenolic bioactives were separated in b 13 min fractions of Maytenus ilicifolia Mart ex. Reissek, J. Ethnopharmacol. 123 (2009)
and the results indicate that Cynara scolymus L. “Globe artichoke” 385–391.
Artichoke, Ptychopetalum olacoides “Marapuama” and Maytenus [19] S. Crestani, Y.D. Rattmann, T.R. Cipriani, L.M. Souza, M. Iacomini, C.A. Kassuya,
M.C. Marques, J.E. Silva-Santos, A potent and nitric oxide-dependent hypotensive
ilicifolia Martius ex Reissek “Espinheira Santa”, marketed in Salvador- effect induced in rats by semi-purified fractions from Maytenus ilicifolia, Vasc.
Bahia-Brazil (plant and phytotherapeutic drugs), are sources of Pharmacol. 51 (2009) 57–63.
antioxidant species. The results showed that the analyzed samples [20] S.E. Drewes, J. George, F. Khan, Recent findings on natural products with erectile-
dysfunction activity, Phytochemistry 62 (2003) 1019–1025.
presented variations in chlorogenic acid, catechin and vanillic acid [21] I.R. Siqueira, C. Fochesatto, I.L.S. Torres, A.L. da Silva, D.S. Nunes, E. Elisabetsky, C.A.
levels, which may represent a risk to patient therapy. Netto, Antioxidant activities of Ptychopetalum olacoides (“muirapuama”) in rat
brain, Phytomedicine 14 (2007) 763–769.
[22] P.M.A. Salomã o, S.K.F. Barroso, M.C.L. Marcellino, Effects of Marapuama
Acknowledgements (Ptychopetalum olacoides Bentham) on reserpine-induced motor changes in mice,
Salusvita 31 (2011) 105–116.
[23] A.F.V.B. Leal, M.O. Berreta, J.R. de Paula, D.G.A. Diniz, M.T.F. Bara, Dissolution
The authors are grateful for the financial support received from profiles of herbal medicines containing Maytenus ilicifolia Mart ex Reiss, Lat. Am. J.
Fundaçã o de Amparo a Pesquisa do Estado da Bahia (FAPESB) and Pharm. 31 (2012) 1108–1116.
Conselho Nacional de Desenvolvimento Científico e Tecnoló gico [24] R. Capasso, A.A. Izzo, L. Pinto, T. Bifulco, C. Vitobello, N. Mascolo, Phytotherapy and
quality of herbal medicines, Fitoterapia 71 (2000) S58–S65.
(CNPq). Research Group: “Biopharmaceutics and Drugs”, State [25] A.F. Santos Jú nior, R.A. Matos, E.M.J. Andrade, W.N.L. dos Santos, H.I.F. Magalhã es,
Universi- ty of Bahia (UNEB). F.N. Costa, M.G.A. Korn, Multielement determination of macro and micro
contents in medicinal plants and phytomedicines from Brazil by ICP OES, J. Braz.
Chem. Soc. 28 (2017) 376–384.
References
[26] O. Sagdic, I. Ozturk, O. Ozkan, H. Yetin, L. Ekici, M.T. Yilmaz, RP-HPLC–DAD
analysis of phenolic compounds in pomace extracts from five grape cultivars:
[1] World Health Organization (WHO), Regional Office for the Western Pacific, Re-
evaluation of their antioxidant, antiradical and antifungal activities in orange
search Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines,
and apple juices, Food Chem. 126 (2011) 1749–1758.
WHO, Manila, 1993.
[27] ANVISA, Resolution RDC-899, 29/05/2003. Guide for Validation of Analytical and
[2] T.M.S. Moreira, H.R.N. Salgado, R.C.L.R. Pietro, Brazil in the context of quality
Bioanalytical Methods. National Health Surveillance Agency. Anvisa, Brasília, Brazil,
control of medicinal plants, Rev. Bras. Farm. 20 (2010) 435–440.
2003.
[3] A.C.B. Carvalho, J.P.S. Perfeito, L.V. Costa e Silva, L.S. Ramalho, R.F.O. Marques, D.
[28] ANVISA, Resolution RDC-31, 11/08/2010. Pharmaceutical Equivalence Studies and
Silveira, Regulation of herbal medicines in Brazil: advances and perspectives, Braz.
Comparative Dissolution Profile. National Health Surveillance Agency. Anvisa,
J. Pharm. Sci. 47 (2011) 467–473.
Brasília, Brazil, 2010.
[4] N.O. Rêgo Jú nior, L.G. Fernandez, R.D. Castro, L.C. Silva, S.A. Gualberto, M.L.A.
Pereira, [29] International Conference on Harmonisation (ICH), Validation of analytical
M.V. Silva, Bioactive compounds and antioxidant activity of crude extracts of proce- dures: text and methodology Q2 (R1)Available at:
caatinga plant species, Braz. J. Food Technol. 14 (2011) 50–57. http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/
[5] H. Peleg, K.K. Bodine, A.C. Noble, The influence of acid on astringency of alum 2005.
and phenolic compounds, Chem. Senses 23 (1998) 371–378. [30] The United States Pharmacopoeia, 33rd Rev., U.S.P. Convention, Rockville, 2011.
[6] L.G. Malta, E.P. Tessaro, M. Eberlin, G.M. Pastore, R.H. Liu, Assessment of antioxidant [31] T.R. Cipriani, C.G. Mellinger, L.M. de Souza, C.H. Baggio, C.S. Freitas, M.C.A. Marques,
and antiproliferative activities and the identification of phenolic compounds of ex- P.A.J. Gorin, G.L. Sassaki, M. Iacomini, Acidic heteroxlans from medicinal plants
otic Brazilian fruits, Food Res. Int. 53 (2013) 417–425. and their anti-ulcer activity, Carbohydr. Polym. 74 (2008) 274–278.
[7] M. Asadi-Samani, N. Kafash-Farkhad, N. Azimi, A. Fasihi, E. Alinia-Ahandani, M. [32] R. Colombo, A.N.L. Batista, G.C.C. Bomfim, R.C.R. Burgos, A.J. Cavalheiro, V.S. Bolzani,
Rafieian-Kopaei, Medicinal plants with hepatoprotective activity in Iranian folk D.H.S. Silva, M.C.H. Reimberg, Validated high-performance liquid
medicine, Asian Pac. J. Trop. Biomed. 5 (2015) 146–157. chromatographic method for the standardisation of Ptychopetalum olacoides
[8] R. Mocelin, M. Marcon, G.D. Santo, L. Zanatta, A. Sachett, A.P. Schö nell, F. Bevilaqua, Benth., Olacaceae, com- mercial extracts, Braz. J. Pharmacogn. 20 (2010) 781–
M. Giachini, R. Chitolina, S.M. Wildner, M.M.M.F. Duarte, G.M.M. Conterato, A.L. 788.
Piato, D.B. Gomes, W.A. Roman Junior, Hypolipidemic and antiatherogenic [33] F.M. Al-Barwani, E.A. Eltayeb, Antifungal compound from induced Conium
effects of Cynara scolymus in cholesterol-fed rats, Rev. Bras. Farm. 26 (2016) maculatum L. plants, Biochem. Syst. Ecol. 32 (2004) 1097–1108.
233–239. [34] J.P. Vistuba, M. Piovezan, M.G. Pizzolatti, A.M. Rebelo, M.S. Azevedo, L. Vitali, A.C.
[9] E. Vamanu, A. Vamanu, S. Nita, S. Colceriu, Antioxidant and antimicrobial Costa, G.A. Micke, Increasing the instrumental throughput of gas
activities of ethanol extracts of Cynara scolymus (Cynarae folium, Asteraceae chromatography method using multiple injections in a single experimental run:
family), Trop. J. Pharm. Res. 10 (2011) 777–783. application in deter- mination of friedelan-3-ol and friedelin in Maytenus
[10] M. Lutz, C. Henríquez, M. Escobar, Chemical composition and antioxidant properties ilicifolia, J. Chromatogr. A 25 (2013) 159–164.
of mature and baby artichokes (Cynara scolymus L.), raw and cooked, J. Food [35] H. Lorenzi, F.J.A. Matos, Medicinal Plants in Brazil: Native and Exotic, 2nd ed
Compos. Anal. 24 (2011) 49–54. Nova Odessa, São Paulo, 2008.
[11] R.S. Costa, E.F. Ozela, W.L.R. Barbosa, N.L. Pereira, J.A.C. Silva, Physical, chemical and [36] BRAZIL, Ministry of Health, National Policy on Integrative and Complementary
physicochemical characterization of the spray-drying of Cynara scolymus L. Prac- tices in SUS - PNPIC-SUS: Attitude to Increase Access, Brasília, Ministry of
(Asteraceae), Rev. Bras. Farm. 90 (2009) 169–174. Health, 2006.
[12] ESCOP Monographs, The scientific foundation for herbal medicinal products, Euro- [37] V. Lattanzio, A. Cardinali, D. Di Venere, V. Linsalata, S. Palmieri, Browning
pean Scientific Cooperative on Phytotherapy, Hederae helicis Folium, Ivy Leaf, 2nd phenom- ena in stored artichoke (Cynara scolymus L.) heads: enzymic or
editionThieme Verlag, Stuttgart, 2003. chemical reaction? Food Chem. 50 (1994) 1–7.
[13] T.R. Cipriani, C.G. Mellinger, L.M. Souza, C.H. Baggio, C.S. Freitas, M.C.A. Marques, [38] F. Fratianni, M. Tucci, M. Palma, R. Pepe, F. Nazzaro, Polyphenolic composition in
P.A.J. Gorin, G.L. Sassaki, M. Iacomini, Polygalacturonic acid: another anti-ulcer dif- ferent parts of some cultivars of globe artichoke (Cynara cardunculus L. var.
scolymus (L.) Fiori), Food Chem. 104 (2007) 1282–1286.